The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 258, Issue 1, Pages 45-63
Publisher
Wiley
Online
2014-02-11
DOI
10.1111/imr.12157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3
- (2014) A. K. Moesta et al. JOURNAL OF IMMUNOLOGY
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Influence of KIR gene copy number on natural killer cell education
- (2013) V. Beziat et al. BLOOD
- NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
- (2013) V. Beziat et al. BLOOD
- CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
- (2013) S Ito et al. BONE MARROW TRANSPLANTATION
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy
- (2013) Q. Zhou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Identification of a KIR antisense lncRNA expressed by progenitor cells
- (2013) P W Wright et al. GENES AND IMMUNITY
- Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
- (2013) G. Peruzzi et al. JOURNAL OF IMMUNOLOGY
- Allelic Variation in KIR2DL3 Generates a KIR2DL2-like Receptor with Increased Binding to its HLA-C Ligand
- (2013) W. R. Frazier et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcR Deficiency
- (2013) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- Effector Mechanisms of Rejection
- (2013) A. Moreau et al. Cold Spring Harbor Perspectives in Medicine
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
- (2012) Lisa M. Pörtner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
- (2012) Ariane Thielens et al. CURRENT OPINION IN IMMUNOLOGY
- Identification of human NK cells that are deficient for signaling adaptor FcR and specialized for antibody-dependent immune functions
- (2012) I. Hwang et al. INTERNATIONAL IMMUNOLOGY
- Skewing of the NK Cell Repertoire by MHC Class I via Quantitatively Controlled Enrichment and Contraction of Specific Ly49 Subsets
- (2012) P. Brodin et al. JOURNAL OF IMMUNOLOGY
- Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation
- (2012) G. F. Lichtfuss et al. JOURNAL OF IMMUNOLOGY
- Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
- (2012) B. Foley et al. JOURNAL OF IMMUNOLOGY
- The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells
- (2012) P Glorius et al. LEUKEMIA
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
- (2011) B. Foley et al. BLOOD
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells
- (2011) Christian Kellner et al. CANCER LETTERS
- A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting
- (2011) Ingo Schubert et al. mAbs
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
- (2011) S. Guia et al. Science Signaling
- Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
- (2010) Kate Stringaris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition
- (2010) K. Schonberg et al. BLOOD
- NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation
- (2010) P. Haas et al. BLOOD
- NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation
- (2010) A. T. Bjorklund et al. BLOOD
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
- (2010) C. G. Brunstein et al. BLOOD
- Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation
- (2010) J. M. Venstrom et al. BLOOD
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells
- (2010) Lucia M. R. Silla et al. BRITISH JOURNAL OF HAEMATOLOGY
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome
- (2010) Jesús García-Foncillas et al. Clinical & Translational Oncology
- Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
- (2010) F. Navid et al. CURRENT CANCER DRUG TARGETS
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Trastuzumab
- (2010) Karly P. Garnock-Jones et al. DRUGS
- Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
- (2010) Nathalie T. Joncker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
- (2010) Julie M. Elliott et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NK Cell Patrolling and Elimination of Donor-Derived Dendritic Cells Favor Indirect Alloreactivity
- (2010) Kym R. Garrod et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells
- (2010) F. Cichocki et al. JOURNAL OF IMMUNOLOGY
- NK Cells Delay Allograft Rejection in Lymphopenic Hosts by Downregulating the Homeostatic Proliferation of CD8+ T Cells
- (2010) D. Zecher et al. JOURNAL OF IMMUNOLOGY
- NK Cell Regulation of CD4 T Cell-Mediated Graft-versus-Host Disease
- (2010) M. N. Rivas et al. JOURNAL OF IMMUNOLOGY
- Effects of IL-2 on MMP Expression in Freshly Isolated Human NK Cells and the IL-2-independent NK Cell Line YT
- (2010) Karin Edsparr et al. JOURNAL OF IMMUNOTHERAPY
- Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
- (2010) M Carlsten et al. LEUKEMIA
- 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
- (2010) Mark T Orr et al. NATURE IMMUNOLOGY
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- (2009) Q. Zhou et al. BLOOD
- Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
- (2009) R. Bari et al. BLOOD
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity
- (2009) C. G. Brunstein et al. BLOOD
- Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
- (2009) C. Fauriat et al. BLOOD
- Requirements for control of B-cell lymphoma by NK cells
- (2009) Christoph D. Brenner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ten years of rituximab in NHL
- (2009) Matthew C Winter et al. Expert Opinion On Drug Safety
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells
- (2009) O. Hershkovitz et al. JOURNAL OF IMMUNOLOGY
- NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
- (2009) N. T. Joncker et al. JOURNAL OF IMMUNOLOGY
- Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
- (2009) Q. Liu et al. JOURNAL OF VIROLOGY
- KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
- (2009) R Willemze et al. LEUKEMIA
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
- (2008) L. Vago et al. BLOOD
- The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations
- (2008) B. A. Foley et al. BLOOD
- Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1
- (2008) M. Stern et al. BLOOD
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element
- (2008) F. Cichocki et al. BLOOD
- The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells
- (2008) P. Brodin et al. BLOOD
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- (2008) S. Cooley et al. BLOOD
- Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
- (2008) S. Laffont et al. BLOOD
- MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response
- (2008) M. Yawata et al. BLOOD
- Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
- (2008) Jumei Shi et al. BRITISH JOURNAL OF HAEMATOLOGY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals
- (2008) B. Foley et al. INTERNATIONAL IMMUNOLOGY
- Accelerated tumor growth in mice deficient in DNAM-1 receptor
- (2008) Akiko Iguchi-Manaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
- (2008) Susan Gilfillan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells
- (2008) Christian Kellner et al. JOURNAL OF IMMUNOTHERAPY
- Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression
- (2008) Hongchuan Li et al. PLoS Genetics
- Regulation of NK cell activity by 2B4, NTB-A and CRACC
- (2007) Maren Claus Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started